SCHEMBL5773858

SCHEMBL5773858

CC(C)c1nc(O)c2nc(-c3ccccc3)cc-2[nH]1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 5/20 0.51
ADORA3 P0DMS8 4/20 0.51
ADORA2A P29274 4/20 0.51
ADORA2B P29275 3/20 0.51
KDM4E B2RXH2 5/20 0.48
CDC7 O00311 3/20 0.43
ALDH1A1 P00352 3/20 0.42
HSD17B10 Q99714 2/20 0.42
HPGD P15428 1/20 0.42
LMNA P02545 1/20 0.41
GSK3B P49841 2/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
POLB P06746 1/20 0.40
MAPT P10636 1/20 0.40
PKM P14618 1/20 0.40
RAB9A P51151 1/20 0.40
PIM1 P11309 1/20 0.39
CSNK2A2 P19784 1/20 0.39
CLK1 P49759 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5774041 0.83 ADORA3 (0.51) ADORA1ADORA3ADORA2AADORA2BKDM4E
SCHEMBL5774357 0.81 ADORA3 (0.48) ADORA1ADORA3ADORA2AKDM4ECDC7
SCHEMBL5771494 0.80 CDC7 (0.48) ADORA1ADORA3ADORA2AKDM4ECDC7
SCHEMBL5769530 0.80 ADORA1 (0.54) ADORA1ADORA3ADORA2AADORA2BKDM4E
SCHEMBL5774884 0.79 CDC7 (0.47) KDM4ECDC7ALDH1A1HSD17B10HPGD
SCHEMBL5777145 0.78 XDH (0.51) ADORA1ADORA3ADORA2AKDM4ECDC7
SCHEMBL5771811 0.78 CDC7 (0.46) ADORA1ADORA3ADORA2AKDM4ECDC7
SCHEMBL5771921 0.77 SMN1; SMN2 (0.55) ADORA1ADORA3ADORA2AADORA2BKDM4E
SCHEMBL5771204 0.77 ALDH1A1 (0.48) KDM4ECDC7ALDH1A1HSD17B10HPGD
SCHEMBL5774772 0.75 ADORA1 (0.53) ADORA1ADORA3ADORA2AADORA2BKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1054887-B1 BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS AMGEN INC (US) 2006-04-12 EP disclosed
US-6583154-B1 Neuropeptide Y antagonist; pyrrolo-(3,2-b)pyridines and pyrrolo-(3,2-d)pyrimidines AMGEN INC. 2003-06-24 US disclosed
US-6187777-B1 PYRROLO(3,2-D)PYRIMIDINE DERIVATIVES; NEUROPEPTIDE Y AND CORTICOTROPIN RELEASING FACTOR MODULATORS; DIETETICS; ANTIDIABETIC, ANTIINFLAMMATORY, AND ANTITUMOR AGENTS AMGEN INC. 2001-02-13 US disclosed
EP-1054887-A1 BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS Amgen Inc. (US) 2000-11-29 EP disclosed
WO-1999040091-A1 BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS AMGEN INC. (US) 1999-08-12 WO disclosed